| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1Physiology and 2Pharmacology, Louisiana State University Health Sciences Center, New Orleans, Louisiana
Submitted 5 December 2006 ; accepted in final form 14 February 2007
Reactive oxygen species (ROS) are implicated in coronary collateral growth (CCG). We evaluated the requirement for ROS in human coronary artery endothelial cell (HCAEC) tube formation, CCG in vivo, and signaling (p38 MAP kinase) by which ROS may stimulate vascular growth. The flavin-containing oxidase inhibitor diphenyleneiodonium (DPI) or the superoxide dismutase inhibitor diethyldithiocarbamate (DETC) blocked vascular endothelial growth factor-induced HCAEC tube formation in Matrigel. We assessed the effect of DPI and DETC on CCG in a rat model of repetitive ischemia (RI) (40 s left anterior descending coronary artery occlusion every 20 min for 2 h 20 min, 3 times/day, 10 days). DPI or DETC was given intraperitoneally, or the NAD(P)H oxidase inhibitor apocynin was given in drinking water. Collateral-dependent flow (measured by using microspheres) was expressed as a ratio of normal and ischemic zone flows. In sham-operated rats, collateral flow in the ischemic zone was 18 ± 6% of normal zone; in the RI group, collateral flow in the ischemic zone was 83 ± 5% of normal zone. DPI prevented the increase in collateral flow after RI (25 ± 4% of normal zone). Similar results were obtained with apocynin following RI (32 ± 7% of that in the normal zone). DETC achieved similar results (collateral flow after RI was 21 ± 2% of normal zone). DPI and DETC blocked RI-induced p38 MAP kinase activation in response to vascular endothelial growth factor and RI. These results demonstrate a requirement for optimal ROS concentration in HCAEC tube formation, CCG, and p38 MAP kinase activation. p38 MAP kinase inhibition prevented HCAEC tube formation and partially blocked RI-induced CCG (42 ± 7% of normal zone flow), indicating that p38 MAP kinase is a critical signaling mediator of CCG.
ischemic zone; vascular endothelial growth factor
This article has been cited by other articles:
|
|
 |
|
  S. Belmadani, K. Matrougui, C. Kolz, Y. F. Pung, D. Palen, D. J. Prockop, and W. M. Chilian Amplification of Coronary Arteriogenic Capacity of Multipotent Stromal Cells by Epidermal Growth Factor Arterioscler. Thromb. Vasc. Biol., June 1, 2009; 29(6): 802 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Reed, B. Potter, E. Smith, R. Jadhav, P. Villalta, H. Jo, and P. Rocic Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1811 - H1821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sasmaz and M. B. Yilmaz Coronary Collaterals in Obese Patients: Impact of Metabolic Syndrome Angiology, April 1, 2009; 60(2): 164 - 168. [Abstract] [PDF]
|
|
|
|
 |
|
 S. H. Schirmer, J. O. Fledderus, P. T.G. Bot, P. D. Moerland, I. E. Hoefer, J. Baan Jr, J. P.S. Henriques, R. J. van der Schaaf, M. M. Vis, A. J.G. Horrevoets, et al. Interferon-{beta} Signaling Is Enhanced in Patients With Insufficient Coronary Collateral Artery Development and Inhibits Arteriogenesis in Mice Circ. Res., May 23, 2008; 102(10): 1286 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Kim, A. Lin, R. E. Guldberg, M. Ushio-Fukai, and T. Fukai Essential Role of Extracellular SOD in Reparative Neovascularization Induced by Hindlimb Ischemia Circ. Res., August 17, 2007; 101(4): 409 - 419. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
